Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism*; D003094:Collagen / Q000494:pharmacology; D004088:Dihydroergotoxine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009947:Organotin Compounds / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D014001:Tin / Q000494:pharmacology; D017971:Tin Compounds; D014220:Trialkyltin Compounds / Q000494:pharmacology
D001095:Arachidonic Acids; D009947:Organotin Compounds; D017971:Tin Compounds; D014220:Trialkyltin Compounds; D004088:Dihydroergotoxine; D016718:Arachidonic Acid; C011559:tributyltin; D000244:Adenosine Diphosphate; C041694:stannic chloride; D014001:Tin; D003094:Collagen; C048581:monotributyltin trichloride; C020735:dibutyldichlorotin; D004837:Epinephrine